ABBV’s PR on FDA approval of Technivie for HCV GT4: http://finance.yahoo.com/news/technivie-ombitasvir-paritaprevir-ritonavir-tablets-180000731.html This is the first FDA approval of any all-oral HCV regimen for GT4.